| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.10. | SPAC Redwoods Acquisition II files for a $75 million IPO, targeting energy storage, telecom, and consumer businesses | ||
| 29.10. | Natural pest control maker Med-X increases shares registered by 23% ahead of Nasdaq direct listing | ||
| 29.10. | SPAC BHAV Acquisition II prices $100 million IPO, targeting robotics, fintech, computing, and energy tech | ||
| 29.10. | Georgia Banking Company announces Nasdaq direct listing on October 29 | ||
| 28.10. | Singapore-based digital ad network Focus Media Network files for a $25 million US IPO | ||
| 28.10. | IPO Weekly Weigh-in: Anthropic's one share to rule them all | ||
| 27.10. | SPAC Heroic Empire Acquisition files for a $100 million IPO, targeting AI, biotech, energy, and manufacturing | ||
| 27.10. | Regenerative medicine device provider RegenLab USA sets terms for $18 million IPO | ||
| 27.10. | SPAC SPACCircle Acquisition prices $100 million IPO, targeting digital assets, tech, and healthcare | ||
| 26.10. | SPAC Aimei Health Technology II increases unit offering by 67% ahead of $100 million IPO | ||
| 26.10. | Laser-based uranium enrichment developer LIS Technologies files for a $17 million IPO | ||
| 26.10. | AI model developer Anthropic PBC files for an estimated $75 billion IPO, teeing up one of the largest-ever IPOs for mid-November | ||
| 26.10. | Parkinson's disease biotech Aspen Neuroscience sets terms for $150 million IPO | ||
| 26.10. | Immunology and inflammation biotech Bambusa Therapeutics sets terms for $150 million IPO | ||
| 24.10. | US IPO Week Ahead: Africa-focused fintech target's week sole IPO as Anthropic nears its public filing | ||
| 24.10. | US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off | ||
| 24.10. | SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO | ||
| 23.10. | Emerging markets fintech OPay sets terms for $320 million US IPO | ||
| 23.10. | Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO | ||
| 23.10. | Lycia Therapeutics prices upsized IPO at $18, the high end of the range | ||
| 22.10. | Inflammatory diseases biotech Rezera files for an estimated $100 million IPO | ||
| 22.10. | Inflammatory diseases biotech Rezera files for a $100 million IPO | ||
| 21.10. | China-based AI vision solutions provider Sensing4D AI files for a $35 million US IPO | ||
| 21.10. | Africa-linked IPOs pick up steam in 2026 | ||
| 20.10. | Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO |